Japan Tissue Engineering Co., Ltd. (TYO:7774)
Japan flag Japan · Delayed Price · Currency is JPY
628.00
-9.00 (-1.41%)
Jul 22, 2025, 3:30 PM JST

Japan Tissue Engineering Company Description

Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan.

The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments.

It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment.

The company also provides tissue-engineered medical products. In addition, it researches and develops human 3-dimensional cultured tissue models for use in the development of cosmetics and drugs for external use, as well as in research that employs skin and cornea tissues.

Further, the company offers regenerative medicine contract development and manufacturing services. The company was founded in 1999 and is headquartered in Gamagori, Japan.

Japan Tissue Engineering Co., Ltd. is a subsidiary of Teijin Limited.

Japan Tissue Engineering Co., Ltd.
CountryJapan
Founded1999
IndustryBiotechnology
SectorHealthcare
Employees204
CEOKazuto Yamada

Contact Details

Address:
6-209-1 Miyakitadori
Gamagori, 443-0022
Japan
Phone81 533 66 2020
Websitejpte.co.jp

Stock Details

Ticker Symbol7774
ExchangeTokyo Stock Exchange
Fiscal YearApril - March
Reporting CurrencyJPY
ISIN NumberJP3389610001
SIC Code3842

Key Executives

NamePosition
Kazuto YamadaChief Executive Officer